Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis use disorder, a small study suggests.
Highlights in poststroke care from ISC 2026 include benefits of asundexian, promise of an investigational revascularization ...
Nonjudgmental and collaborative care plans are ideal for primary care clinicians treating patients with obesity.
Perioperative morbidity and mortality were reduced with off-pump vs on-pump coronary artery bypass grafting, though survival ...
Fecal microbiota transplants may enhance patients’ response to immunotherapy, but experts caution that the latest data remain proof-of-concept and far from practice-changing.
GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...
Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data ...
The vaccine plus a booster dose reduces the odds of preeclampsia by 30% and by as much as 58% in those with preexisting ...
Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.
Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.
Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...
MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results